Sublocade (buprenorphine extended-release)

Sublocade is a prescription medication that contains buprenorphine, a powerful tool in treating opioid addiction. Unlike other forms of buprenorphine that come in tablet form, The drug is administered through a monthly injection under the skin. This method ensures controlled delivery of the medication and reduces the risk of misuse or diversion.

Sublocade works by binding to opioid receptors in the brain, effectively blocking the rewarding effects of other opioids. By doing so, it helps to alleviate withdrawal symptoms and cravings, allowing individuals to focus on their recovery without the constant urge to use opioids.

Opioids, also known as opiates, are natural and synthetic drugs that interact with the nervous system to relieve pain. he most abused opioids are heroin, fentanyl, morphine, and prescription painkillers like OxyContin, Vicodin, and Demerol.

Buprenorphine works as a partial agonist at the opioid receptors. It mitigates the subjective effects of opioid withdrawal, decreases opioid cravings, and blocks the drug-like effects of opioids themselves. Buprenorphine is the main active ingredient in Sublocade.

Sublocade is administered as a subcutaneous injection by a healthcare professional. The injection is typically given once a month, providing a continuous release of buprenorphine throughout the treatment period. The standard dosage of Sublocade is a 300 mg injection for the first two months, followed by a 100 mg injection for maintenance treatment.

The drug gradually releases a controlled dosage of buprenorphine into the body over time, blocking the rewarding effects of opioid drugs.

Those who receive Sublocade usually do as part of a complete treatment program for people with opioid use disorder. The Food and Drug Administration (FDA) has warned against the use of Sublocade for persons who have conditions such as:

• Respiratory depression
• Chronic obstructive pulmonary disease (COPD)
• Sleep apnea

Studies have shown that Sublocade injection is an effective treatment for opioid addiction. In addition to reducing cravings and opioid withdrawal symptoms, the slow-release feature of Sublocade has been associated with a lower risk of treatment dropout. This means that individuals are more likely to stay engaged in their recovery journey, increasing their chances of success.

Length of treatment varies depending on the individual and the severity of the addition. Our program is designed to be a minimum of six months. At the end of the six months, and at regular intervals during the course of your addiction treatment, the clinical team will review progress in treatment and will work with the client to identify the best next steps for their long-term recovery.

As with any medication, buprenorphine may cause side effects, although not everyone experiences them. Common side effects of Sublocade include

• Constipation
• Headache
• Nausea
• Vomiting
• Pain at the injection site

These side effects are generally mild and subside over time.

It is important to note that Sublocade is a controlled substance due to its potential for misuse and dependence. Individuals with a history of substance use disorders should exercise caution when using the medication and follow their healthcare provider’s instructions carefully.

There is potential for developing a dependency to Sublocade because it contains buprenorphine, a low-level opioid that is less intense than other opioids but still has addictive properties.

If administered by a medical professional, overdose is rare. However, it is possible to overdose on Sublocade, especially if taken with alcohol or other drugs. An individual experiencing an overdose should seek immediate medical attention as symptoms could cause long-term damage or death.

Sublocade represents a significant advancement in the treatment of opioid use disorder. By providing sustained release and alleviating cravings and withdrawal symptoms, buprenorphine offers individuals a chance to regain control of their lives and work toward lasting recovery. Combined with counseling and support, Sublocade plays a vital role in comprehensive medication-assisted treatment, paving the way for a brighter future for those struggling with opioid addiction.